Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 3.2B | 3.1B | 3.3B |
Cost of revenue | 1.3B | 1.3B | 1.4B | 1.4B |
Gross profit | 1.9B | 1.9B | 1.8B | 1.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.3B | 1.3B | 1.4B |
Other operating expenses | 4.3M | 11.1M | -10.2M | 8.5M |
Operating income | 642.1M | 527.6M | 475.6M | 600.2M |
Non operating interest income | ||||
Income | 11.1M | 11.1M | — | — |
Expense | 91.4M | 91.4M | 126.4M | 82.0M |
Other income expense | -59.8M | -56.4M | -99.0M | -25.6M |
Pretax income | 502.0M | 391.0M | 295.4M | 492.6M |
Tax provision | 143.4M | 116.1M | 45.3M | 165.6M |
Net income | 358.6M | 274.9M | 250.2M | 327.0M |
Basic EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 775.3M | 654.9M | 651.4M | 754.8M |
Net income from continuing op. | 358.6M | 274.9M | 250.2M | 327.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |